| Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma E Saâda-Bouzid, C Defaucheux, A Karabajakian, VP Coloma, V Servois, ... Annals of Oncology 28 (7), 1605-1611, 2017 | 622 | 2017 |
| Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC … JM Hannoun-Levi, A Resch, J Gal, D Kauer-Dorner, V Strnad, P Niehoff, ... Radiotherapy and Oncology 108 (2), 226-231, 2013 | 165 | 2013 |
| Unconjugated bisphenol A cord blood levels in boys with descended or undescended testes P Fenichel, H Dechaux, C Harthe, J Gal, P Ferrari, P Pacini, ... Human reproduction 27 (4), 983-990, 2012 | 136 | 2012 |
| Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome J Doyen, C Trastour, F Ettore, I Peyrottes, N Toussant, J Gal, K Ilc, D Roux, ... Biochemical and biophysical research communications 451 (1), 54-61, 2014 | 120 | 2014 |
| Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey J Barrière, J Gal, B Hoch, O Cassuto, A Leysalle, E Chamorey, ... Annals of Oncology 32 (5), 673-674, 2021 | 103 | 2021 |
| Can we increase the chance of sphincter saving surgery in rectal cancer with neoadjuvant treatments: lessons from a systematic review of recent randomized trials JP Gerard, Y Rostom, J Gal, D Benchimol, C Ortholan, C Aschele, ... Critical reviews in oncology/hematology 81 (1), 21-28, 2012 | 97 | 2012 |
| Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas E Saâda-Bouzid, F Burel-Vandenbos, D Ranchère-Vince, ... Modern pathology 28 (11), 1404-1414, 2015 | 90 | 2015 |
| Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points … F Bonnetain, B Bonsing, T Conroy, A Dousseau, B Glimelius, ... European journal of cancer 50 (17), 2983-2993, 2014 | 77 | 2014 |
| Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study JP Gérard, N Barbet, J Gal, C Dejean, L Evesque, J Doyen, R Coquard, ... European Journal of Cancer 108, 1-16, 2019 | 71 | 2019 |
| Cord blood thyroid tests in boys born with and without cryptorchidism: correlations with birth parameters and in utero xenobiotics exposure F Brucker-Davis, P Ferrari, M Boda-Buccino, K Wagner-Mahler, P Pacini, ... Thyroid 21 (10), 1133-1141, 2011 | 65 | 2011 |
| Long-term quality of life and psycho-social outcomes after oropharyngeal cancer surgery and radial forearm free-flap reconstruction: a GETTEC prospective multicentric study A Bozec, P Demez, J Gal, E Chamorey, MY Louis, D Blanchard, ... Surgical oncology 27 (1), 23-30, 2018 | 60 | 2018 |
| Brachytherapy versus external beam radiotherapy boost for prostate cancer: Systematic review with meta-analysis of randomized trials DLC Kee, J Gal, AT Falk, R Schiappa, ME Chand, M Gautier, J Doyen, ... Cancer treatment reviews 70, 265-271, 2018 | 59 | 2018 |
| 18F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions O Humbert, V Bourg, L Mondot, J Gal, PY Bondiau, D Fontaine, ... European journal of nuclear medicine and molecular imaging 46, 558-568, 2019 | 52 | 2019 |
| Organ or sphincter preservation for rectal cancer. The role of contact X-ray brachytherapy in a monocentric series of 112 patients AC Frin, L Evesque, J Gal, K Benezery, E François, J Gugenheim, ... European journal of cancer 72, 124-136, 2017 | 52 | 2017 |
| Hyperprogression under immune checkpoint inhibitor: a potential role for germinal immunogenetics S Refae, J Gal, P Brest, D Giacchero, D Borchiellini, N Ebran, F Peyrade, ... Scientific Reports 10 (1), 3565, 2020 | 51 | 2020 |
| Exposure to selected endocrine disruptors and neonatal outcome of 86 healthy boys from Nice area (France) F Brucker-Davis, K Wagner-Mahler, L Bornebusch, I Delattre, P Ferrari, ... Chemosphere 81 (2), 169-176, 2010 | 50 | 2010 |
| Salvage mastectomy versus second conservative treatment for second ipsilateral breast tumor event: a propensity score-matched cohort analysis of the GEC-ESTRO breast cancer … JM Hannoun-Levi, J Gal, E Van Limbergen, ME Chand, R Schiappa, ... International Journal of Radiation Oncology* Biology* Physics 110 (2), 452-461, 2021 | 48 | 2021 |
| Iodine status has no impact on thyroid function in early healthy pregnancy F Brucker-Davis, P Ferrari, J Gal, F Berthier, P Fenichel, S Hieronimus Journal of thyroid research 2012 (1), 168764, 2012 | 48 | 2012 |
| Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitors S Refae, J Gal, N Ebran, J Otto, D Borchiellini, F Peyrade, E Chamorey, ... Investigational New Drugs 38, 160-171, 2020 | 46 | 2020 |
| Accelerated partial breast irradiation in the elderly: 5-Year results of the single fraction elderly breast irradiation (SiFEBI) phase I/II trial JM Hannoun-Lévi, DLC Kee, J Gal, R Schiappa, A Hannoun, Y Fouche, ... Brachytherapy 19 (1), 90-96, 2020 | 44 | 2020 |
olivier dassonvillechirurgien ORL, spécialiste CLCC, université de Nice, FranceZweryfikowany adres z nice.unicancer.fr
